Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with systemic sclerosis (SSc, also called scleroderma) according to a specific set of internationally recognised classification rules from 2013.
- People who have been confirmed through heart and lung pressure testing to have pulmonary arterial hypertension (high blood pressure in the lungs), where the cause is not primarily lung scarring or heart disease.
- People who are able to understand and follow the trial steps, including filling in questionnaires about how they feel and function day to day.
- People who have access to the internet and have some experience using a smartphone or other internet-connected device.
- People who are able to give their signed agreement to participate after being informed about the trial.
Who may not be able to join:
- People with severe heart failure where the heart's pumping function is very low (ejection fraction below 30%).
- People with advanced kidney disease where kidney function has dropped significantly (eGFR below 30 mL/min).
- People with severely reduced lung function (FVC below 50%), or serious lung conditions such as advanced COPD or emphysema (GOLD grade 3–4 with FEV1 below 50%).
- People with other significant lung problems that the trial doctor considers clinically important.
- People currently receiving treatment for cancer, or who have a cancer that cannot be cured.
- People with very high or very low blood pressure, or a resting heart rate above 130 beats per minute, which would make physical fitness testing unsafe.
- People who have had heart surgery, a heart attack, unstable chest pain, a collapsed lung, or a stroke within the past 8 weeks.
- People with severe movement, muscle, or nerve problems that would make walking tests unsafe, or who have an acute illness that the trial doctor believes would affect safety or test results.
- People who are not able to speak, write, and read Norwegian.
- People who are pregnant or planning to become pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anna-Maria Hoffmann-Vold, MD, PhD, Oslo University Hospital
Phone: 0047 92884573
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of Home Monitoring: Patient Adherence and Compliance; Feasibility of Home Monitoring: Technical Feasibility; Feasibility of Home Monitoring: Agreement Between Home-Based 1MSTS and Hospital-Based 6MWD for Exercise Capacity Assessment; Feasibility of Home Monitoring: Agreement Between Home-Based and Hospital-Based Peripheral Oxygen Saturation (SpO₂) at Rest and Nadir During Exercise; Feasibility of Home Monitoring: Agreement Between Home-Based and Hospital-Based Heart Rate Measurements at Rest, Peak Exercise, and Recovery; Feasibility of Home Monitoring: Agreement Between Home-Based...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.